Stepping into the sunshine

Is the imminent release of the database of industry's 'gifts' to doctors cause for concern or celebration? Charles Schmidt investigates.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Timeline for the roll out of the OPP.


  1. 1

    Bhandari, M. et al. CMAJ 170, 477–480 (2004).

    PubMed  PubMed Central  Google Scholar 

  2. 2

    Borrell, B. A medical Madoff: anesthesiologist faked data in 21 studies. Sci. Am. (10 March 2009).

  3. 3

    Harris, G. & Carey, B. NY. Times (Print) Researchers fail to reveal full drug pay. (8 June 2008).

  4. 4

    Vox, F. ProPublica goes after the wrong man in its 'Dollars for Docs' crusades. Forbes (3 April 2014).

  5. 5

    Ornstein, C. & Jones, R.G. Double dip: doctors paid to advise, promote drug companies that fund their research. The Boston Globe and ProPublica (25 March 2014).

  6. 6

    Seiffert, D. Mass. doctors are getting fewer gifts from drug and device companies. Boston Business Journal (29 April 2014).

  7. 7

    Seiffert, D. Bad medicine: why life sciences companies are crying foul over new transparency rules. Boston Business Journal (20 June 2014).

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Schmidt, C. Stepping into the sunshine. Nat Biotechnol 32, 859–862 (2014).

Download citation

Further reading